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Abstract: Background
Health care practice needs to be underpinned by high quality research evidence, so
that the best possible care can be delivered. However, evidence from research is not
always utilised in practice.  This study used the Promoting Action of Research
Implementation in Health Services (PARIHS) framework as its theoretical underpinning
to test whether two different approaches to facilitating implementation could affect the
use of research evidence in practice.
Methods
A pragmatic clustered randomised controlled trial with embedded process and
economic evaluation was used. The study took place in four European countries
across 24 long term nursing care sites, for people aged 60 years or more with
documented urinary incontinence.  In each country, sites were randomly allocated to
standard dissemination, or one of two different types of facilitation. The primary
outcome was the documented percentage compliance with the continence
recommendations, assessed at baseline, then at 6, 12, 18 and 24 months after the
intervention.
Data were analysed using STATA10, linear regression models were fitted to scores for
compliance with continence recommendations, adjusting for clustering.
Results
Quantitative data were obtained from reviews of 2313 records. There were no
significant differences in the primary outcome (documented compliance with
continence recommendations) between study arms and all study arms improved over
time.
Conclusions
This was the first cross European randomised controlled trial with embedded process
evaluation that sought to test different methods of facilitation. There were no
statistically significant differences in compliance with continence recommendations
between the groups.  It was not possible to identify whether different types and "doses"
of facilitation were influential within very diverse contextual conditions. The process
evaluation (linked paper) revealed the models of facilitation used were limited in their
ability to overcome the influence of contextual factors.
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Response to Reviewers: Reviewer 1
Reviewer Comment
a)If ACT was collected at baseline, I don't follow how it is listed as a secondary
'outcome'. I guess if only measured at baseline it should be reported much earlier in
the results section.
Response:ACT was also collected at 12 and 24 months, however, this data is not
available for all sites at 12 months and 24 months. In this paper it is the baseline data
(the organisational context at the point of implementation) that seemed most relevant
and we are really using ACT as an explanatory variable rather than as a secondary
outcome variable in this paper. We would prefer to leave the results related to ACT at
the end of the findings section.
Comment: b)Typically, ICCs are higher for process measures than for more distal
outcomes. process measures in primary care often have an ICC of 0.1 and outcome
measures more like the stated 0.01. I appreciate the additions made in regard to ICCs -
I might suggest that a revised sample size calculation could be helpful for readers.
Response: Retrospective sample size calculations are a statistically controversial issue
and we do not think it will help the reader in this case. We have now included, at the
suggestion of one of the other referees, the post estimation ICCs that follow from the
fitting of the regression models.
Comment: c)If ACT was similar across sites, how do we understand differences
observed across countries and sites? maybe ACT doesn't capture contextual factors
relevant to improvement in these processes or relevant to responsiveness to the
intervention?
Response: Thank you for this comment. We address this in the discussion section of
our paper. The issue of whether ACT is sensitive to change we do not discuss as we
have only used baseline data from ACT in this paper so do not examine change in
ACT scores. The team of researchers that developed ACT are engaged in studies that
are examining the sensitivity of ACT to change and this may be reported in a
subsequent paper, but as stated in our response to your first point, we do not have
data for all sites at 12 and 24 months.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Reviewer 3
Reviewer Comment
a)The primary outcomes are three measures of 'compliance with continence
recommendations' (resident screened; assessed; treatment plan; specialist referral)
(abstract and in the methods p11). We are not clear how these are measured. Is this a
percentage compliance at the level of the patient or the cluster? (nursing care site). If
the latter, the regression models (tables 2 4 6 8) only include 24 units. We have
assumed in the following comments that the analysis is based on patient-level
outcomes. It would be helpful to expand the description of the outcomes in the
methods section to explain how the measures have been constructed. Add a N=   at
the bottom of all the tables, to give the overall population, making clear whether these
are sites or patients.
Response: Percentage compliance is at the resident level. A sentence has been added
on page 9 in the outcome measures section. Supplementary file 1 provides details of
the components of each of the recommendations. For each resident the percentage
compliance with a recommendation is the total number of components of that
recommendation that the documentation indicates have been complied with divided by
the number of components and expressed as a percentage.
N=2313 has been added to the bottom of tables 1-7 to make clear that these tables
present an analysis at the resident level.
Table 8 presents a summary of the staff responses to the ACT questionnaire, N=725
has been added to the title of this table so it is clear how many staff responses the
table is based on overall.
Comment b)The analysis of the primary outcomes (three measures of compliance with
continence recommendations) uses linear regression models. This is a cluster
randomised trial with multiple levels (country, site, staff, patient). In a cluster
randomised trial it is usual to perform an analysis which adjusts for clustering at the
unit of randomisation, which in this case is nursing care site, and this is what is
described. 'Regression' covers a range of different analyses, and in this case
presumably some sort of multilevel model was used to adjust the standard errors to
take site level clustering into account so it would be helpful to add in exactly which
stata command was used to fit the regression models (e.g. mixed, xtmixed). It would be
helpful to add a statement that the assumptions of linear regression have been
examined and the data meets those assumptions,
Response: We agree with the referee that this study could be considered to have
multiple levels. We have considered data at the resident level and clustering is at the
site level. Country has been included as a covariate. With regard to the primary
outcomes we have no information about staff so this cannot be considered as a level in
the trial design.
In the previous version of the paper the models were linear regression models in which
the standard errors were specified as robust (cluster) with the site as the cluster
variable. This corrects the standard errors through the sandwich method (Huber-White
method), inflating the se’s to correct for the clustering.
We have also fitted a multi-level mixed effect linear regression model (using the
STATA15 mixed command, again with site as the level variable and SE set to
robust(cluster)). The estimates are very similar to those from the simpler model we
reported in the previous version, some of the se’s are increased a little and none of the
conclusions from the models are changed. We have decided to update the results
tables 2, 4, 6 to show the results from the multi-level mixed effect linear regression to
be sure we have taken full account of the clustering. We have amended the
explanation of the model fitting on page 11, to clarify what was done.
We have added a statement about the assumptions on page 13-14.
Comment
c)ICCs were calculated on the baseline data and we find this confusing. Once a
multilevel model has been fitted to the data, it is usually possible to extract an overall
ICC at the level of clustering which would be based on all data points (not just
baseline) - see https://www.stata.com/features/overview/intraclass-correlations-for-
multilevel-models/
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Response:
The reason for calculating the ICCs at baseline is these are the values which, had they
been available, we would have used in the sample size calculation.
We have, as you suggested, calculated the post-estimation ICC for each of the
regression models. These post estimation ICCs are reported at the end of tables 2, 4
and 6 and in the text relating to the results for each of the three compliance variables
(pages 14-16).
This analysis was not available in version 10 of STATA (the version we had been using
for the analysis). We have therefore rerun all the analyses in STATA version 15 and
throughout the text updated STATA10 to STATA15.
Comment: d)There were only 24 sites (clusters) and both 'country' and 'intervention'
are fitted at a site level and have a total of 5 individual covariates between them - it is
doubtful there is enough data here to provide stable estimates: We'd recommend that
the authors try removing 'country' from the analysis as a sensitivity analysis to check
that results are similar.
Response: We agree with the reviewers that the number of sites is small relative to the
number of levels of the covariates. As the reviewers suggest have re-run the analysis
removing country from the analysis as a sensitivity check. There is still no significant
intervention effect for any of the three recommendations if country is removed. The
results are similar, so the estimates appear to be reasonably stable. This has been
noted in on page 13-14.
Comment e)Patients were recruited to this trial post randomisation - which means that
recruiters already knew which arm of the trial a site was in before consenting patients.
This lack of allocation concealment can lead to differential recruitment in a cluster
randomised trial - e.g. differences in numbers recruited or the type of patients recruited.
We can see little information on which to judge whether or not this was a problem. We
can't find a consort flow diagram and this would be helpful (and recommended by
CONSORT)  - how many patients were approached but did not consent, and how
many consented but did not provide outcome data? Baseline compliance in the control
group was much higher than in the intervention group (table 3) and this could be an
indication of differential recruitment. Perhaps the authors can make some comment on
this.
Response: On page 10 in the section Sample size and power calculation it says
“Consent was sought at cluster and at individual level, the former before randomisation
and the later after randomisation.”  On page 11 in the section on allocation
concealment and blinding it said “It was not possible to blind sites to intervention,
although research fellows who collected data were initially blinded to intervention
group.”
This sentence has been reworded (on page 11) to make it clear that where it was
necessary to obtain consent from individual residents for outcome data collection this
consent was obtained by the research fellow who was initially blind to the intervention
allocated for the site.
To clarify for the reviewers, consent from residents was not necessary for access to
records in Netherlands, Sweden or Ireland. All data from records was collected by the
country research fellow who was blinded to the intervention group to which the care
home had been allocated, so recruitment of resident records would not have been
influenced by lack of allocation concealment. In UK, consent from residents (or their
family) was necessary for access to the resident record. This consent was obtained by
the research fellow who was unaware of which intervention the care home had been
allocated. We noted that once the research fellows were in the long term care setting,
the blinding could inadvertently be broken by the site, for example, mentioning the
name of an external facilitator working with them, and thus revealing the allocation of
that site.  In all countries the consent of the resident or their family was necessary from
the collection of EQ5D, this consent was obtained by the research fellow.
The study flow diagram is in supplementary file 4.
Comment f)How similar were patient demographics across groups? The paper would
benefit from a table of baseline characteristics, by group. Provide mean(SD) for
continuous variables, number(%) for categorical and median (IQR) for ordinal or non-
normal, and include both the number included for each measure plus the overall total.
It is not good practice to compare the groups using statistical tests (as described on
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page 11 and shown in table 1).
Response: The only resident demographic information that was collected was age and
gender. We prefer not to introduce a further table to report this information by group,
but we have included it within the text on page 12 in the description of resident sample.
Whilst we agree with the reviewers that using statistical tests to compare groups is not
considered by everyone to be good practice, however it is a widely used practice. We
only do this for demographic data and some secondary outcomes because we think
some readers would expect (or prefer) to have evidence of statistical tests alongside
statements of similarity or difference. With regard to Table 1 we have included 95%
CI’s for those who prefer this approach to describing similarity or difference between
groups.
Comment: g)EQ5D-VAS is reported (table 1) at 24 months only (because of least
amount of missingness at that time point). It was collected at several time points,
suggesting it might be an outcome measure, but it is not reported as such.
Response: The reviewers observation that EQ5D might have been a secondary
outcome measure is correct. However, there were difficulties with the process of
getting resident consent for collection of this data and process of getting this measure
completed with the resident. Over time the issues related to consent and process were
resolved sufficiently so that at the 24 month data collection point this measure was
available for 77% of residents. Given the difficulties with collecting this data earlier in
the trial we decide this measure could not be used as a secondary outcome. We did
however, feel that the more complete 24 month data was helpful in providing a
description of the health status of the residents.
Comment: h)Table 3 and 5 both suggest an effect in favour of the 2 intervention arms,
and the effect is quite close to the 15 percentage point difference anticipated in the
power calculation (Table 7 does not). This, combined with the very wide confidence
intervals, might indicate that there is a hint of an effect here, but that there is
insufficient power to detect a difference. We like the way the authors have used the
findings from the process evaluation to explain the results: however, they cannot write
off the idea that there may have been an effect, and the lack of power may be more of
an issue than suggested in the conclusion.
Response: We agree with the reviewers’ observation that given the lack of power we
cannot write off the idea that there may have been an effect from one or both of the
intervention arms, and this is addressed in the limitations. We feel that the text on page
14 already identifies that Tables 3 and 5 show some improvement in the intervention
arms, but given the large variability associated with the means reported and the lack of
power we are reluctant to put any further emphasis on these results. As the reviewers
note the confidence intervals are very wide.
Comment: i)Secondary outcomes at patient level seem to have been reported as a
difference between baseline and 24 months, rather than compared by group. These
outcomes should be reported as described in the methods, using Anova or chi squared
tests, as appropriate, or even using regression methods
Response: All the secondary outcomes at patient level are binary outcomes we have
therefore used chi-squared test to compare the groups at 24 months and this
information has been added on page 16-17. As further exploration of the differences
found between baseline and 24 months we feel it is helpful to look at changes within
the intervention groups, so the changes within intervention group previously reported
remain in the text.
Comment: j)Given the lack of power in the study, we would very tentatively suggest
that the authors give consideration to combining both arms and comparing facilitation
against control, although this analysis was not anticipated and would have to be
reported very carefully.
Response: Although the study was not designed with the intention of combining
facilitation arms, the analysis has been rerun comparing facilitation (combining the
groups Type A and type B) against control and there is no evidence that the facilitation
is more effective than control.
Additional Information:
Question Response
<b>Is this study a clinical Yes
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trial?</b><hr><i>A clinical trial is defined
by the Word Health Organisation as 'any
research study that prospectively assigns
human participants or groups of humans
to one or more health-related
interventions to evaluate the effects on
health outcomes'.</i>
We require registration of all clinical trials
that are reported in manuscripts submitted
to the journal. More information about trial
registration, including the trial registries
that currently meet all of the ICMJE
guidelines, can be found in the FAQ
section of "About ICMJE" at <a
href="http://www.icmje.org/about-
icmje/faqs/clinical-trials-registration/"
target="_blank">http://www.icmje.org/abo
ut-icmje/faqs/clinical-trials-
registration/</a>.<p>Please provide the
following information where
prompted:<hr>Enter the Trial Registration
Number:<br/>&emsp;as follow-up to
"<b>Is this study a clinical
trial?</b><hr><i>A clinical trial is defined
by the Word Health Organisation as 'any
research study that prospectively assigns
human participants or groups of humans
to one or more health-related
interventions to evaluate the effects on
health outcomes'.</i>"
ISRCTN11598502
Enter the name of the
registry:<br/>&emsp;as follow-up to
"<b>Is this study a clinical
trial?</b><hr><i>A clinical trial is defined
by the Word Health Organisation as 'any
research study that prospectively assigns
human participants or groups of humans
to one or more health-related
interventions to evaluate the effects on
health outcomes'.</i>"
Current Controlled Trials
Enter the URL of the trial registry
record:<br/>&emsp;as follow-up to "<b>Is
this study a clinical trial?</b><hr><i>A
clinical trial is defined by the Word Health
Organisation as 'any research study that
prospectively assigns human participants
or groups of humans to one or more
health-related interventions to evaluate
the effects on health outcomes'.</i>"
https://doi.org/10.1186/ISRCTN11598502
Enter the date that you registered your
trial (in mm/dd/yyyy
format):<br/>&emsp;as follow-up to "<b>Is
this study a clinical trial?</b><hr><i>A
clinical trial is defined by the Word Health
Organisation as 'any research study that
prospectively assigns human participants
or groups of humans to one or more
health-related interventions to evaluate
the effects on health outcomes'.</i>"
04-02-2010
Enter the date of enrolment of the first
participant to the trial (in mm/dd/yyyy
01-03-2010
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format):<br/>&emsp;as follow-up to "<b>Is
this study a clinical trial?</b><hr><i>A
clinical trial is defined by the Word Health
Organisation as 'any research study that
prospectively assigns human participants
or groups of humans to one or more
health-related interventions to evaluate
the effects on health outcomes'.</i>"
Was your trial registered before the first
participant was enrolled? (i.e.
prospectively registered)<br/>&emsp;as
follow-up to "<b>Is this study a clinical
trial?</b><hr><i>A clinical trial is defined
by the Word Health Organisation as 'any
research study that prospectively assigns
human participants or groups of humans
to one or more health-related
interventions to evaluate the effects on
health outcomes'.</i>"
Yes
Within your manuscript, have you also
included details of your trial registration at
the end of your abstract?
Name of the registry•
Trial registration number•
Date of registration•
URL of trial registry record•
Example: Trial registration: ISRCTN,
ISRCTN12345678. Registered 28
September 2014,
http://www.isrctn.com/ISRCTN12345678
 as follow-up to "Was your trial
registered before the first participant was
enrolled? (i.e. prospectively registered)"
I confirm I have provided trial registration details at the end of the abstract
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Facilitating Implementation of Research Evidence (FIRE): an international cluster randomised 49 
controlled trial to evaluate two models of facilitation informed by the Promoting Action in Research 50 
Implementation in Health Services (PARIHS) framework 51 
Abstract  52 
Background 53 
Health care practice needs to be underpinned by high quality research evidence, so that the best 54 
possible care can be delivered. However, evidence from research is not always utilised in practice.  55 
This study used the Promoting Action of Research Implementation in Health Services (PARIHS) 56 
framework as its theoretical underpinning to test whether two different approaches to facilitating 57 
implementation could affect the use of research evidence in practice.    58 
Methods 59 
A pragmatic clustered randomised controlled trial with embedded process and economic evaluation 60 
was used. The study took place in four European countries across 24 long term nursing care sites, for 61 
people aged 60 years or more with documented urinary incontinence.  In each country, sites were 62 
randomly allocated to standard dissemination, or one of two different types of facilitation. The 63 
primary outcome was the documented percentage compliance with the continence 64 
recommendations, assessed at baseline, then at 6, 12, 18 and 24 months after the intervention.  65 
Data were analysed using STATA15, multi-level mixed effects linear regression models were fitted to 66 
scores for compliance with the continence recommendations, adjusting for clustering.  67 
Results 68 
Quantitative data were obtained from reviews of 2313 records. There were no significant differences 69 
in the primary outcome (documented compliance with continence recommendations) between 70 
study arms and all study arms improved over time.  71 
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Conclusions 72 
This was the first cross European randomised controlled trial with embedded process evaluation that 73 
sought to test different methods of facilitation. There were no statistically significant differences in 74 
compliance with continence recommendations between the groups.  It was not possible to identify 75 
whether different types and “doses” of facilitation were influential within very diverse contextual 76 
conditions. The process evaluation (linked paper36) revealed the models of facilitation used were 77 
limited in their ability to overcome the influence of contextual factors.   78 
 79 
Trial Registration: Current Controlled Trials ISRCTN11598502.  Date 4/2/10. 80 
https://doi.org/10.1186/ISRCTN11598502 81 
The research leading to these results has received funding from the European Union's Seventh 82 
Framework Programme (FP7/2007-2013) under grant agreement n° 223646. 83 
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Background 87 
It is important that health care practice is underpinned by high quality research evidence, so that the 88 
best possible care can be delivered. However, evidence from research is not always utilised in 89 
practice.1-3  This study used the Promoting Action of Research Implementation in Health Services 90 
(PARIHS) framework4 as its theoretical underpinning to test whether two different approaches to 91 
facilitation could affect the use of research evidence in practice.   The PARIHS framework was built 92 
upon an argument that three factors influence the uptake of research evidence in practice: the 93 
nature (strength) of the evidence, the context in which it is used, and the extent of facilitation (or 94 
help) that people have to use the evidence.  The published protocol for this study5 and an online 95 
summary report for the funder6 contains further details. 96 
Consistent with recent calls for an increase in theory-based implementation research,7 we used the 97 
PARIHS framework and identified two alternative types of facilitation to evaluate within the FIRE 98 
Study.  We chose to evaluate facilitation because whilst it is a promising approach to 99 
implementation; it has received relatively little attention and the limited results available of its 100 
effectiveness were mixed.8-10 Facilitation has been described as a process and a role.11  More recently 101 
it has been argued12 “conceptual ambiguities” challenge our understanding of facilitation’s 102 
effectiveness and we do not know how to “appropriately set the degree of facilitation.” It is clear 103 
from the literature that the role and effectiveness of facilitation in implementing evidence into 104 
practice needs to be explored and tested.   This study was novel in scale with a cross-country setting, 105 
and in that it sought to compare facilitation approaches that varied in terms of focus, duration and 106 
intensity. 107 
Urinary incontinence in long term care settings is a major issue and was thus selected as an 108 
exemplar for evaluating different approaches to implementing evidence into practice. Incontinence 109 
is a “discrediting and stigmatising” condition that affects quality of life.13  It has a high prevalence in 110 
long term care settings, between 40-70%,14 and it is a key priority within international health 111 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
7 
 
policy.15 The relevance and fit of the PARIHS framework in long term care settings for older people16 112 
highlighted that the factors discussed as important for change in their setting showed a good fit with 113 
those identified in the PARIHS framework, and recommended its use in these settings. We designed 114 
the FIRE trial to test two different approaches to facilitation and compare these against standard 115 
dissemination of recommendations for continence promotion.5  116 
Aims: We aimed to extend knowledge of facilitation as a process for getting research evidence into 117 
practice by testing the effectiveness of and evaluating the contribution two different models of 118 
facilitation can make to implementing evidence based urinary continence recommendations into 119 
practice. 120 
The objectives of the study were to: 121 
1) Extend existing knowledge of facilitation as a process for translating research evidence into 122 
practice. 123 
2) Evaluate the feasibility and effectiveness of two different models of facilitation in promoting the 124 
uptake of research-based recommendations on continence promotion, compared with standard 125 
dissemination.  126 
3) Advance existing knowledge of guideline implementation in healthcare, with a particular focus on 127 
understanding the impact of contextual factors on the processes and outcomes of implementation. 128 
4) Implement a pro-active dissemination strategy that complements the design of the study and 129 
facilitates the diffusion of the study findings to a wide policy and practice community throughout 130 
Europe and beyond.  This objective is not considered further in this paper. 131 
  132 
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Methods   133 
Design 134 
A pragmatic cluster randomised controlled trial with embedded process and economic evaluation 135 
was undertaken.  The process evaluation is reported in a linked paper (Rycroft-Malone et al36).  136 
Participants  137 
Staff:  An Internal facilitator (a member of staff from the long-term care setting) nominated in each 138 
intervention site to work with external facilitators (EFs) to implement the urinary incontinence (UI) 139 
recommendations.   140 
Residents: aged 60 years or more with documented urinary incontinence.  141 
Setting  142 
The study took place in four European countries (England, Sweden, Netherlands, Republic of 143 
Ireland), and each country planned to recruit six long term nursing care sites (nursing homes and 144 
other residential settings with long term nursing care) (total 24 sites) for people aged 60 years or 145 
more with documented urinary incontinence.  All settings had publicly funded places. 146 
The intervention  147 
In arm one, the eight settings randomised to the standard dissemination control group had the 148 
urinary continence recommendations and a PowerPoint presentation on implementation (based on 149 
one utilised by Rycroft-Malone et al17) sent to the head of each site. Both the intervention groups 150 
also received the same as the standard dissemination sites.  151 
In addition, EFs prepared two different facilitator development programmes, each of which involved 152 
an initial residential programme, followed by virtual support (monthly telephone group supervision 153 
and email communication) for the internal facilitators (IFs) in implementing the UI 154 
recommendations.   Arm two received a type of facilitation that we termed ‘type A’, which is a goal 155 
focused approach to facilitation based on principles of quality improvement, management studies 156 
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and organisational learning.   This involved a 12 month programme for IFs nominated by each of the 157 
eight sites in this arm. This started with the IFs taking part in a three day residential programme run 158 
by two EFs (GH & AK), followed by 10 days over 12 months to work locally on the implementation 159 
and evaluation of recommendations, supported by 12 half days for monthly teleconferences and 160 
self-directed study (16 days in total).  161 
Arm three received a type of facilitation that we termed ‘type B’, which is underpinned by principles 162 
of stakeholder empowerment and overcoming external and internal obstacles to using research 163 
evidence in practice. This is achieved through the creation of workplace cultures of effectiveness in 164 
which work-based learning as inquiry is valued and supported at all levels of the organisation. This 165 
approach is informed by critical social theory and holistic facilitation. IFs nominated by each of the 166 
eight settings participated in a 24-month development programme. This started with a five-day 167 
residential programme run by two EFs (BMcC & AT) followed by 20 days to work on the local 168 
implementation and evaluation of the recommendations, supported by 24 half day learning groups 169 
via teleconferencing, and 12 half days for self-directed study (38 days in total). The EFs each have 170 
over 20 years’ experience of facilitation. Supplementary File 1 contains more details on the 171 
underpinning theories and activities in each intervention. 172 
A model of co-facilitation was used in both facilitation arms where a second staff member in the 173 
organisation, a “buddy”, worked with the IF, using this as a development opportunity, including 174 
taking the lead if the initial facilitator was unable to continue.  175 
Outcomes Measures 176 
The primary outcome was the documented percentage compliance with continence 177 
recommendations produced by the fourth International Consultation on Incontinence.18 Percentage 178 
compliance is calculated for each resident, so is measured at the resident level. 179 
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These recommendations included 1) the resident should be actively screened for incontinence (five 180 
components), 2) a detailed assessment should be carried out (15 components), 3) an individualised 181 
treatment plan should be in place (13 components) and 4) a specialist referral should be made if 182 
needed (one component). These outcomes were assessed at baseline, then at 6, 12, 18 and 24 183 
months. Supplementary File 2 lists all components of the continence recommendations. 184 
Secondary outcomes included the documented incidence of level of cognitive impairment (as this 185 
influences the type of continence care the guidance recommends), depression, incontinence related 186 
dermatitis, urinary tract infections (UTIs), health related quality of life (EQ-5D19 and IQoL20) and the 187 
proportion of residents in the setting with incontinence and use of pelvic floor exercises.  188 
Organisational context was assessed using the Alberta Context Tool (ACT). 21,22 The ACT data was 189 
collected from Nurses, Licenced Practical Nurses (LPN) and Health Care Assistants (HCA) at baseline 190 
in 23 of the 24 sites.  191 
Sample Size and Power calculations: There was no information on existing compliance with the 192 
continence recommendations. We took a 50% compliance as an initial assumption. It was assumed 193 
that each setting would have 50 residents available for assessing compliance. For 90% power to 194 
detect compliance of 15% better in the intervention compared to control arm and allowing for an 195 
intra-cluster correlation of 0.01 (typically found in Primary Care Studies23)and statistical tests carried 196 
out at the 5% level, for a cluster size of 50, seven clusters (long term care settings) were required per 197 
intervention arm. Thus 7x3 arms=21 clusters were needed.  Allowing for potential attrition, this was 198 
increased to eight clusters per arm, so 24 clusters in total. This equates to 6 long term nursing care 199 
settings in each of the four countries with 50 or more residents per setting. Consent was sought at 200 
cluster and at individual level, the former before randomisation and the latter after randomisation. 201 
Randomisation sequence generation, allocation concealment, implementation and blinding 202 
In each country, sites were randomly allocated to one of three arms (standard dissemination, and 203 
two different intensities and kinds of a facilitation intervention), using a random sequence 204 
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generated by the statistician. A centralised randomisation point was set up by the study statistician 205 
to ensure allocation concealment. Long term care settings were enrolled by country leads for the 206 
study. The statistician was blinded to the intervention group. It was not possible to blind site staff to 207 
intervention. Research fellows who collected data from records and where necessary obtained 208 
consent from residents were blinded to the intervention group, but as discussed in the protocol5, 209 
previous experience suggested this blinding may be inadvertently broken by the sites.  210 
  211 
Quantitative Analysis – Statistical Methods: Data were analysed using STATA15. The primary 212 
outcome measures, percentage compliance, were analysed by fitting multi-level mixed effects linear 213 
regression models with standard errors adjusted for the clustering at the level of the nursing care 214 
setting (site level).24  Data was collected every six months, but because the resident population was 215 
constantly changing it is necessary to consider the data as repeated cross-sectional assessments of 216 
residents in the care settings rather than longitudinal assessment of individuals within the care 217 
settings. The regression models include three independent variables: study arm (three levels), 218 
country (four levels), time period (five levels baseline, 6 months, 12 months, 18 months, 24 months), 219 
interaction terms would only be fitted if study arm main effects were significant. Intra-cluster 220 
correlation coefficients (ICC) for the baseline measurements of the compliance scores were 221 
calculated through ANOVA with adjustment for clustering and unequal cluster size. Post-estimation 222 
ICCs are calculated after fitting the regression models. Descriptive statistics, ANOVA and chi-square 223 
tests were used, where appropriate, to examine differences between groups with regard to 224 
secondary outcomes. Data were examined by an independent data monitoring committee. 225 
Qualitative Analysis: The process evaluation data were analysed from a realist perspective25 and are 226 
reported in the linked paper (Rycroft-Malone et al36). 227 
Findings 228 
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In each country, we planned to recruit six sites (two sites per arm). This happened for Sweden and 229 
the Netherlands. However, one site in England withdrew before the study started. When no 230 
additional site was forthcoming in England within the timeframe, an additional control site was 231 
recruited in Republic of Ireland, and ethical clearance obtained. This final site had data collected up 232 
to month 18 only as there was not time to collect data at 24 months.  There were thus five sites in 233 
England (with one site in the control arm) and seven in the Republic of Ireland (three sites in the 234 
control arm).  Each cluster (site) received the allocated intervention and were analysed for primary 235 
and secondary outcomes. 236 
Quantitative data were available from 2313 resident records across all time points (n=430 at baseline, 237 
n=462 at 6 months, n=497 at 12 months, n=479 at 18 months and n= 445 at 24 months after the 238 
intervention).  The sample is described and then the primary outcome, compliance with the four 239 
continence recommendations is presented. The study took place between 2010 and 2013.  240 
Description of resident sample  241 
Most residents were included at one time point only.  In all four countries, at baseline the mean age 242 
of residents varied from 82-87 years. This was almost unchanged at 24 months later (range 82-86 243 
years). In all four countries there were more female than male residents at baseline (the percentage 244 
female in each site ranged from 60-71%), and this was similar at 24 months (range 54-80% females). 245 
At baseline the mean age of residents allocated to the three intervention groups was very similar 246 
(Control 85.34 years (s.d. 7.39); Type A 86.35 years (s.d. 7.19); Type B 83.20 years (s.d. 8.48)). The 247 
gender mix was also similar for the three intervention groups (Control 68.8% female; Type A 62.2% 248 
female; Type B 73.8%). 249 
To understand the health status of the residents, data from the EQ-5D visual analogue scale (VAS) 250 
measure of health state that we administered at 24 months provides summary information for each 251 
intervention group (Table 1). Data at 24 months are chosen because EQ-5D-VAS was available for a 252 
higher proportion of residents than any other time point. Higher scores on a scale of 0-100 represent 253 
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better health states.  Table 1 shows there was no significant difference in the mean EQ-5D scale for 254 
the intervention groups; so on average resident health status was similar in all the intervention 255 
groups. Not all residents were able to complete or have a proxy complete an EQ-5D so numbers 256 
completed are lower than total number of residents. 257 
Table 1 here 258 
Primary Outcomes – compliance with the four continence recommendations 259 
(Full details of all the components of each of the four continence recommendations are 260 
available in the supplementary file 1). The ICC for percentage compliance with 261 
recommendations has been calculated from the baseline data, making allowance for both 262 
the clustering and the unequal numbers from the 24 long term care settings. The ICC for 263 
percentage compliance with recommendation 1 is 0.545 (95% CI 0.361, 0.730); for 264 
percentage compliance with recommendation 2 the ICC is 0.404 (95% CI 0.220, 0.587) and 265 
for percentage compliance with recommendation 3 ICC was 0.455 (95% CI 0.270, 0.641). 266 
These ICCs are much higher than expected and those usually found in Primary Health Care 267 
studies of 0.0123 they are more similar to those found in some educational cluster trials.26 268 
 The results reported in tables 2, 4 and 6 are from fitting multi-level mixed effect linear regressions 269 
models to the compliance scores for each of the recommendations 1,2 and 3 respectively. These 270 
models account for the cluster design by treating site as a random effect and adjusting the standard 271 
error for the 24 site clusters. The model includes three independent variables: study arm (three 272 
levels – control, Type A and Type B), country (four levels – Netherlands, Sweden, Republic of Ireland 273 
and England), time period (five levels: baseline, 6 months, 12 months, 18 months, 24 months). The 274 
first level for each variable (Control arm for intervention, Netherlands for country and baseline for 275 
time) are taken as the base level and other levels are compared to this. In this model we are 276 
considering the effect of intervention allowing for country and time. The assumptions of linear 277 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
14 
 
regression were examined and there was no evidence that the data failed to meet these 278 
assumptions. As a sensitivity analysis the linear regression models were also fitted omitting the 279 
country covariate and this did not change any of the findings with regard to the significance of the 280 
intervention effect. 281 
Compliance with Recommendation 1: The resident should be actively screened for urinary 282 
incontinence   283 
Compliance with recommendation 1 can range from 0 to 5 depending on which of five potential 284 
components of this recommendation are documented.  For each component documented one point 285 
is scored, percentage compliance is a score out of 5 as a percentage. Table 2 reports the model for 286 
compliance with recommendation 1 and shows outcome scores in the intervention arms did not 287 
reach statistical significance. Country is significant with Sweden having poorer compliance (a 288 
negative coefficient) compared to the Netherlands. Ireland and England had significantly better 289 
compliance than the Netherlands (positive coefficients). The 12 and 24 month data collection 290 
parameters were significant, but the other points were not significantly different to baseline. The 291 
post-estimation ICC following the fitting of this model for compliance with recommendation 1 is 292 
0.091. Table 3 shows the mean percentage for each intervention group at each time point, showing 293 
the small increase in percentage compliance score for type A and type B intervention up to 12 294 
months, though as the regression model indicates there is no significant difference in the study arms 295 
over the duration of the study. 296 
Table 2 here 297 
Table 3 here 298 
Compliance with Recommendation 2: A detailed assessment should be carried out 299 
There are 15 items in the detailed assessment, so scores can range from 0-15 for recommendation 2.  300 
Percentage compliance is a score out of 15 as a percentage. 301 
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Table 4 reports the fitted model for compliance with recommendation 2.  The intervention is not 302 
effective; neither the Type A facilitation or Type B facilitation interventions had significant 303 
coefficients. Ireland was significantly different having higher compliance with recommendation 2, 304 
but the coefficients for the other countries were not significant, so England and Sweden are not 305 
significantly different to the Netherlands after allowing for time point and intervention group. The 306 
24 month data collection parameter is significant, with increased compliance by 24 months, but the 307 
other points are not significantly different to baseline. The post-estimation ICC following the fitting 308 
of this model for compliance with recommendation 2 is 0.351. Table 5 shows mean percentage 309 
compliance score for recommendation 2 by intervention group. Mean percentage compliance was 310 
low at baseline, in all groups, but improved by 24 months in the Type A and Type B intervention 311 
groups.  312 
Table 4 here 313 
Table 5 here 314 
Compliance with Recommendation 3: An individualised treatment plan should be in place 315 
A score from 0 to 13 is possible for compliance with recommendation 3.  Percentage compliance is a 316 
score out of 13 as a percentage. 317 
Table 6 reports the fitted model for compliance with recommendation 3. The intervention was not 318 
effective, neither the Type A facilitation or Type B facilitation interventions had significant 319 
coefficients. All country parameters were significant with Sweden, Ireland and England all having 320 
significantly higher compliance with recommendation 3 than the Netherlands. All time points were 321 
significant, and the parameter value increased for each successive time period, thus suggesting 322 
improvement over time in compliance with recommendation 3. This suggests learning over time in 323 
all countries but no significant difference in the effectiveness of the three study interventions. The 324 
post-estimation ICC following the fitting of this model for compliance with recommendation 3 is 325 
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0.126. Table 7 shows mean percentage compliance for recommendation 3 by intervention group.  It 326 
can be seen that all three groups appear to improve over time, with little difference between the 327 
interventions as indicated by the regression model.  328 
Table 6  here 329 
Table 7 here 330 
Recommendation 4: Specialist referral should be made if necessary 331 
There were very few specialist referrals made and in the data collection it was not always clear 332 
whether a lack of documentation meant no referral was made or whether a referral was not 333 
necessary. It is therefore difficult to fully assess compliance with this guideline. However, the level of 334 
referral was so low that it is very unlikely that study arm has a significant impact on compliance with 335 
this recommendation. In only 4% of residents was a referral recommended. Although these referrals 336 
were recorded as specialist referrals, 17 were to a general practitioner (family doctor) and 6 to an 337 
unknown specialist. There were only 11 referrals to a continence specialist nurse and six referrals to 338 
urology. 339 
In summary, for the primary outcome (documented compliance score or percentage compliance 340 
with continence recommendations) there was no significant difference between study arms; all 341 
study arms improved over time in all countries. 342 
Secondary (clinical) outcomes  343 
These data are being considered as two cross-sectional reviews of the resident populations in the 344 
long term care settings as there are very few individual residents included at both baseline and 24 345 
months data collection. At 24 months there was no significant difference between the three 346 
intervention groups with regard to the proportion of residents who had no documented record of 347 
the assessment of cognition (p=0.076 from chi-square test).  At 24 months there was a significant 348 
difference between the three intervention groups with regard to the proportion of residents who 349 
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had no documented record of the level of cognitive impairment (p<0.001 from chi-squared test), the 350 
proportion being higher in the control group than in the Type A and Type B groups. At 24 months 351 
there was a significant difference between the three intervention groups with regard to the 352 
proportion of residents who had no documented record of the assessment of depression (p=0.017 353 
from chi-squared test), the proportion being higher in the control group than in the Type A and Type 354 
B groups. At 24 months there was no significant difference between the three intervention groups 355 
with regard to the proportion of residents who had no documented record of the assessment of 356 
incontinence related dermatitis (p=0.479 from chi-square test). 357 
Between baseline and 24 months there was a statistically significant decrease in the proportion of 358 
residents who had no documented record of an assessment of cognition in Type B facilitation 359 
(p<0.001) but no significant change for Type A; there was a significant decrease in the proportion of 360 
residents who have no documented record of the level of cognitive impairment in intervention Type  361 
A (p<0.001) and Type B (p<0.001); there was a significant reduction in the percentage of residents 362 
who had no documentation of assessment of depression in the Type A (p<0.001) and Type B 363 
(p<0.001) groups. There was a significant decrease in the percentage of residents who had no 364 
documentation of incontinence associated dermatitis between baseline and 24 months in the Type A 365 
(p<0.001) and Type B (p<001) groups. There was no significant improvement in the control group for 366 
any of the secondary outcomes. 367 
Whether the impact of urinary incontinence on quality of life been assessed was not documented 368 
for the majority of residents. It was not assessed more than seven times in any group, so this was 369 
not explored further. Very few UTIs were documented. In the month prior to the baseline data 370 
collection only 15 UTIs were recorded in all countries, decreasing to only seven at the 24 month data 371 
collection point. No further analysis was done.  372 
It was not possible to reliably calculate the proportion of residents in each long term care setting 373 
with incontinence, thus no further analysis was done. At baseline pelvic floor exercises were not 374 
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used with any residents and at 24 month follow up pelvic floor exercises were only used with 3 375 
residents. With such low numbers, no further exploration of this is sensible. 376 
In summary, for secondary outcomes, both the facilitation intervention groups (Type A and Type B) 377 
showed significantly better documentation of three outcomes: the level of cognitive impairment, 378 
depression and incontinence associated dermatitis between baseline and 24 months, and this 379 
improvement did not occur in the standard dissemination (control) group. Clinically this change was not 380 
large, and a substantial proportion of residents still had no documented assessment of level of cognitive 381 
impairment (68% in Type A and 65% in Type B) depression (61% in Type A and 65% in Type B) and 382 
incontinence associated dermatitis (66% in Type A and 73% in Type B).   383 
There was a large amount of missing data on the Urinary Incontinence Quality of Life (I-QoL) 384 
outcome measure20 as residents found it too much to complete, so this is not reported further. It 385 
had been planned to report length of stay data, but it was not possible to collect this data 386 
consistently across all sites, so it is not reported further. 387 
Health economics 388 
Health Economic analysis was undertaken, but since there was no significant difference in the 389 
primary outcome between the intervention groups, these data are not presented here in detail 390 
because the cost analysis showed that, as expected, standard dissemination would be the least 391 
costly intervention to implement. (see supplementary file 3 for intervention cost tables) 392 
Alberta Context Tool 393 
For all concepts, higher scores represent a better work context. All responses for a site (Nurse, LPN, 394 
HCA) were considered together to provide an overall picture of the site. The questionnaire 395 
completed by Nurses, LPN’s and HCAs were identical except with regard to informal interactions in 396 
which the HCA group had one less question (9) than the other groups of staff who had 10 questions 397 
in this section. 398 
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Table 8 here 399 
Table 8 shows for each concept the mean score given by all staff rating a site within the intervention 400 
arm. Formal interactions are notably lower than other scores. The largest differences are for 401 
structural and electronic resources and for organisational slack - space. On the basis of the similarity 402 
of these mean scores we conclude the study groups were similar with regard to ACT concepts.  403 
Discussion 404 
The 12 months Type A and the 24 months Type B facilitation interventions did not have different 405 
levels of impact on documented compliance with recommendations. It was thus not possible to 406 
identify the type and “dose” of facilitation that worked best within the highly varied contextual 407 
conditions identified in this study. In addition, the process evaluation revealed important issues 408 
about the models of facilitation used and the characteristics of the facilitators (see linked paper 409 
Harvey et al37).  410 
So why was it that the facilitation intervention did not make a statistically significant difference to 411 
the documented implementation of continence recommendations?  Was an element of the PARIHS 412 
framework, facilitation, purported to be necessary for getting research evidence used in practice, 413 
actually not so important?  Other research has found some type of help with getting research 414 
implemented does make a difference.27,28 Baskerville et al’s29 systematic review of practice 415 
facilitation in primary care suggests facilitation improves uptake of clinical practice guidelines by 416 
nearly three times. A facilitation intervention was found to reduce neonatal mortality by 50%.30 417 
Although the facilitation not working in this study is a possible explanation and the high ICCs meant 418 
the study was underpowered, the process evaluation qualitative research evidence (linked paper 419 
Rycroft-Malone et al36) suggested this was not the most likely explanation. It may be facilitation 420 
works differently along the continuum of context.  It could be that using only documented evidence 421 
of compliance with the recommendations under- estimated what might have happened in practice 422 
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but was not documented.  A lack of intervention fidelity is another possible explanation, and this is 423 
addressed in the process evaluation paper (linked paper Rycroft-Malone et al36).  424 
Although the intervention groups improved, it was not possible to say the improvement was due to 425 
the intervention as the control group also improved.  We do not know why this was, but it could be 426 
that for control sites, being in the study, including 6 monthly follow-ups for two years, was enough 427 
of an incentive to improve.   However, the qualitative data suggests for most control sites they did 428 
not use the written recommendations or the implementation guide.  One site mentioned to the 429 
researcher that they checked their documentation and practice knowing the researcher would be 430 
visiting, and thus even collecting follow-up data in the control group can be seen as having an effect.  431 
Etheridge et al31 concluded that four active ingredients were required to effect change in long term 432 
care settings: urgency, solidarity, intensity and accumulation. The continence programme they 433 
reviewed failed and one of the reasons they identified may also apply in our study: there was no 434 
buy-in from participants. Although all sites agreed to take part in the study, the topic area and the 435 
intervention were already decided. In addition, participants changed during the study, so, for 436 
example, as managers changed, new managers did not necessarily see this study as a priority, thus 437 
reducing even further the extent of organisational buy-in and support (see linked paper36).  438 
The proposition that underpins the PARIHS framework is that successful implementation is a 439 
function of the nature of the evidence being implemented, the context into which it is being 440 
implemented and appropriate facilitation to help people implement the evidence.   There was no 441 
weighting given to these three aspects of evidence, context and facilitation.  This research suggested 442 
that facilitation with one or two people in a team may not easily overcome contextual factors. The 443 
level of experience and expertise of the IF, and relationship of the IF to managers in the setting may 444 
be more important32 as may unravelling how facilitation and context interact. 445 
It was not possible to identify a “good enough” model of facilitation that affected the primary 446 
outcome (documented compliance with continence recommendations) and could address the 447 
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different contexts. Facilitation did however result in some identifiable practice changes (e.g. new 448 
assessment processes, new forms, and awareness of the impact of incontinence on residents).  449 
It may be that in practice, tailoring the type of facilitation to both the setting and the internal 450 
facilitator is important.  Just how one could map the contextual characteristics to a type of 451 
facilitation and to type of internal facilitator would need further evaluation. Van der Zijpp et al,32 452 
part of this study, argued the interactions between managerial leaders and IFs were important, 453 
summarised by three themes: realising commitment, negotiating conditions and encouraging to 454 
keep the momentum going. The reciprocal relationships between managers and IFs influenced the 455 
process of implementation and future interventions should target managers in a focused way. In 456 
studies that evaluate implementation of complex interventions such as facilitation, it may be 457 
appropriate to adopt a theoretical perspective on fidelity, focusing on the intended mechanisms of 458 
the intervention. For example, in this study the theory of Type A facilitation required IFs to develop 459 
skills and confidence in audit and feedback. Achieving this mechanism, even if it meant IFs needed 460 
varying levels of external facilitation, would demonstrate theoretical fidelity. This type of approach 461 
has been proposed in public health33 and is discussed in more depth in the linked papers (Rycroft-462 
Malone et al36, Harvey et al37). 463 
ACT considers organisational concepts as a unit-based score. In this study these were considered as 464 
site level variables. Mean baseline and follow-up mean scores were compared with either an ANOVA 465 
where multiple time points were available or with a t-test when only one follow-up time point was 466 
available. There were very few changes that were significant. We are thus not confident to make any 467 
claims about the effects of the intervention on organisational culture as assessed with ACT. Possible 468 
explanations for this include the organisations were stable and at site level the concepts were 469 
unaffected by the interventions.  470 
 471 
Limitations 472 
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In reality, the planned interventions did not always work as originally envisaged, as revealed by the 473 
process evaluation36 and our analysis of the facilitation intervention37. This was for several reasons, 474 
relating to: initial selection and preparation of the IFs; engagement in the facilitation intervention; 475 
ability to progress according to plan. The linked papers illustrate the issues that compromised the 476 
fidelity of the intervention (Rycroft-Malone et al36 linked paper).  It was also challenging to recruit 477 
resident participants in some homes, so we had fewer than planned.  In addition, although each of 478 
the long term settings had agreed to take part, for individual staff within the home it was not 479 
necessarily a priority. The unexpectedly high ICC meant the study was underpowered.  Although we 480 
felt the ICC we used in the sample size calculation was reasonable, in planning future cluster RCTs 481 
with a more educational focus, it is important to be aware that not all ICCs will be as low as those 482 
reported for recent primary care trials. 23  In the design of the study it was assumed that there would 483 
not be large country differences regarding compliance with the recommendations, hence it would 484 
be viable to have a small number of sites from each country in each study arm. In practice it appears 485 
the countries are behaving differently, but the study was not powered to investigate within country 486 
effect of the different interventions on the primary outcome.  487 
Conclusions 488 
Pressman & Wildavsky34 a long time ago reported that “the study of implementation requires 489 
understanding that apparently simple sequences of events depend on complex chains of reciprocal 490 
interaction” (pxvii) and referred to the complexities of implementation as “the lumpy stuff of life”35 491 
(p165). This study supports those assertions. 492 
This was the first cross European randomised controlled trial with embedded process and economic 493 
evaluations that sought to test different methods of facilitation. There was no significant difference 494 
in the primary outcome between any of the three study arms.  It found both models of facilitation 495 
were broadly viable but were not significantly better than a control in improving documented 496 
compliance with recommendations to promote continence. Contextual issues were not always 497 
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overcome by the approaches to facilitation adopted in this study as our linked papers demonstrate 498 
(Rycroft-Malone et al, Harvey et al36,37).  499 
Declarations 500 
Ethics approval and consent to participate 501 
Ethical Committee approval was obtained in England (10/WSE04/20), Sweden (2009/1806-31/2), 502 
and Republic of Ireland (ECM4(u)02/03/10). In the Netherlands, the researchers followed advice to 503 
get permission from either an ethical committee at site level, or where this did not exist, from a 504 
scientific or residents committee at the site (HAZ-11087777-JGS). Research Governance approval 505 
was also obtained in England and permission to collect data at the sites obtained in Sweden and 506 
Republic of Ireland. 507 
Consent for publication 508 
Consent form allowed the use of anonymised quotations in publications.    509 
Availability of data and materials 510 
The datasets generated or analysed during the current study are not publicly available because 511 
consent to make data publicly available was not part of the consent by participants.   512 
Competing interests – We acknowledge that CE is involved in the development of the Alberta 513 
Context Tool and AK GH JRM BMcC KS and AT have all been involved in the development of the 514 
PARIHS framework. 515 
Funding 516 
The research leading to these results has received funding from the European Union's Seventh 517 
Framework Programme (FP7/2007-2013) under grant agreement n° 223646. 518 
 Authors' contributions 519 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
24 
 
All authors read and approved the final manuscript. 520 
KS (principal investigator) led the application for funding. She contributed to the overall design of 521 
the study, designed the cluster RCT aspect of the study, and contributed to the analysis. She led the 522 
writing of this paper. 523 
JRM (collaborator) participated in designing the study. She led the design of the evaluation package 524 
and was country co-ordinator for England. She wrote the process evaluation aspects of this paper 525 
and reviewed the manuscript critically for important intellectual content.  526 
KC (collaborator) participated in designing the study and reviewed the manuscript critically for 527 
important intellectual content. She was country co-ordinator for the Netherlands.  528 
NC (statistician) advised on study design, contributed to the analysis plan and undertook the analysis 529 
within the cluster RCT, and reviewed the manuscript critically for important intellectual content. 530 
 RTE and CJ (health economists) were responsible for the economic evaluation study design and  531 
reviewed the manuscript critically for important intellectual content.  532 
ACE (research fellow) participated in the design and analysis of the evaluation package, collected 533 
data in Sweden, contributed to the analysis and reviewed the manuscript critically for important 534 
intellectual content. 535 
 CAE (collaborator) participated in study design and coordinated the use of the Alberta context tool 536 
including its translation into Swedish and Dutch. She reviewed the manuscript critically for important 537 
intellectual content.  538 
CH (research fellow) participated the design of the process evaluation and associated data collection 539 
tools, the development of the economic evaluation, and was responsible for the day to day running 540 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
25 
 
of the process evaluation, contributed to the data collection in England and the analysis and 541 
reviewed the manuscript critically for important intellectual content. 542 
GH (collaborator) participated in the design of the overall study and in the design of the facilitator 543 
intervention in particular. She co-led Type A facilitation work package and reviewed the manuscript 544 
critically for important intellectual content. 545 
AK (collaborator) participated in the design of the overall study and in the design of the facilitator 546 
intervention in particular. She co-led Type A facilitation work package and reviewed the manuscript 547 
critically for important intellectual content. 548 
BMcC (collaborator) participated in the design of the overall study and in the design of the 549 
facilitation intervention in particular. He co-led Type B facilitation work package and reviewed the 550 
manuscript critically for important intellectual content. He was also Country Coordinator for Ireland.  551 
CM (research fellow) participated in the design of the RCT and associated data collection tools, 552 
participated the collection of data in England, contributed to the analysis and reviewed the 553 
manuscript critically for important intellectual content. 554 
AT (collaborator) participated in the design of the overall study, especially the Type B facilitation 555 
intervention. She co-led Type B facilitation work package and reviewed the manuscript critically for 556 
important intellectual content. 557 
PS and CMcC (research fellows) participated the collection of data in Republic of Ireland, contributed 558 
to the analysis and reviewed the manuscript critically for important intellectual content. 559 
TN and TvdZ (research fellows) participated the collection of data in Netherlands, contributed to the 560 
analysis and reviewed the manuscript critically for important intellectual content. 561 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
26 
 
LW (collaborator) participated in the design of the overall study and in the design of the intervention 562 
evaluation in particular. He reviewed the manuscript critically for important intellectual content and 563 
was Country Coordinator for Sweden.  564 
 565 
Acknowledgements 566 
Thank-you to all those who were involved in this study as participants or who advised us on the 567 
study. 568 
 569 
Note to editorial assistant: 570 
Please note that references to Rycroft Malone et al and Harvey et al as linked papers refer to two 571 
papers already accepted by Implementation Science which will be published together with this paper. 572 
I will reference those fully when I have this information from Implementation Science. Reference 36 573 
and 37 in the list. 574 
References  575 
1. Grol R. Success and failures in the implementation of evidence-based guidelines for clinical 576 
practice. Medical Care. 2001; 39(8 Suppl 2):1146–1154 577 
2. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA. The quality of care 578 
delivered to adults in the United States. New England Journal of Medicine. 2003; 348(26):2635–579 
2645.  580 
3. Katikreddi SV, Higgins M, Bond L, Bonnell C, Macintyre S. How evidence based is English public 581 
health policy? BMJ 2011;343:d7310 582 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
27 
 
4. Kitson A, Rycroft-Malone J, Harvey G, McCormack B, Seers K, Titchen A. Evaluating the successful 583 
implementation of evidence into practice using the PARIHS framework: Theoretical and practical 584 
challenges, Implementation Science, 2008; 3:1 doi:10.1186/1748-5908-3-1  585 
5. Seers K, Cox K, Crichton NJ, Tudor-Edwards R, Eldh A, Estabrooks CA, Harvey G, Hawkes C, Kitson 586 
A, Linck P, McCarthy G, McCormack B, Mockford C, Rycroft-Malone J, Titchen A, & Wallin, L. FIRE 587 
(Facilitating Implementation of Research Evidence): a study protocol. Implementation Science 2012; 588 
7: 25 doi:10.1186/1748-5908-7-25 589 
6. Seers K, Cox K, Crichton NJ, Tudor-Edwards R, Eldh A, Estabrooks CA, Harvey G, Hawkes C, Kitson 590 
A, Linck P, McCarthy G, McCormack B, Mockford C, Rycroft-Malone J, Titchen A, & Wallin L. (2013) 591 
Final Report Summary - FIRE (Facilitating Implementation of Research Evidence) 592 
http://cordis.europa.eu/result/rcn/149765_en.html. Accessed 03/04/18 593 
7. Eccles MP, Armstrong D, Baker R, Cleary K, Davies H, Davies S, Glasziou P, Ilott I, Kinmonth AL, 594 
Leng G, Logan S, Michie S, Rogers H, Rycroft-Malone J, Sibbald B. An implementation research 595 
agenda. Implementation Science 2009; 4:18 doi:10.1186/1748-5908-4-18 596 
8. Grimshaw JM, Thomas RE, MAcLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles M, 597 
Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C. Effectiveness and efficiency of guideline 598 
dissemination and implementation strategies. Health Technology Assessment   2004; 8:6 599 
9. Thompson DS, Estabrooks CA, Scott-Findlay S, Moore K, Wallin L. Interventions aimed at 600 
increasing research use in nursing: a systematic review. Implementation Science. 2007; 2:15. 601 
http://www.implementationscience.com/content/pdf/1748-5908-2-15.pdf 602 
10. Medves J, Godfrey C, Turner C, Paterson M, Harrison M, MacKenzie L, Durando P.  603 
Systematic review of practice guidelines dissemination and implementation strategies for healthcare 604 
teams and team-based practice. Int J Evidence Based Healthcare. 2010; 8:78-89  605 
doi:10.1136/bmj.a2390 606 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
28 
 
11. Dogherty EJ, Harrison MB, Graham ID. Facilitation as a role and process in achieving evidence-607 
based practice in nursing: a focused review of concept and meaning. Worldviews Evidence Based 608 
Nursing. 2010; 7(2):76–89. 609 
12. Berta W, Cranley L, Dearing JW, Dogherty EJ, Squires JE and Estabrooks CA.  Why (we think) 610 
facilitation works: insights from organizational learning theory. Implementation Science. 2015; 611 
10:141 DOI 10.1186/s13012-015-0323-0 612 
13. Brittain KR, Shaw C. The social consequences of living with and dealing with incontinence – a 613 
carers perspective. Social Science and Medicine. 2007; 65:1274-1283 614 
14. Ouslander JG & Schnelle JF. Incontinence in the nursing home. Ann Intern Med. 1995;122(6):438-615 
449 616 
15. National Guideline Clearinghouse. Guideline for Urinary Incontinence in the long term setting. 617 
American Medical Directors Association. Agency For Healthcare Research and Quality. 2012; 618 
http://www.guideline.gov/content.aspx?id=45526. Archived. 619 
https://www.guideline.gov/summaries/archive/withdrawn/771#jumptoU. Accessed 3/4/18 620 
16. Perry L, Bellchambers H, Howie A, Moxey A, Parkinson L, Capra S, Byles J. Examination of the 621 
utility of the Promoting Action on Research Implementation in health Services framework for 622 
implementation of evidence based practice in residential aged care settings. Journal of Advanced 623 
Nursing. 2011; 67(10):2139-2150 ;67(10):2139-50 624 
17. Rycroft-Malone J, Seers K, Crichton N, Chandler J, Hawkes C, Allen C, Bullock I, Strunin L. A 625 
pragmatic randomised controlled trial evaluating three implementation interventions. 626 
Implementation Science. 2012; 7:80. 627 
18. DuBeau CE, Kuchel GA, Johnson T, Palmer MH, Wagg A.  Committee 11. Incontinence in the frail 628 
elderly. In: Abrams P, Cardozo L, Khoury S & Wein A (eds) . Incontinence. 4th International 629 
Consultation on Incontinence. Health Publications Limited. 2009; pp961-1024 and pp1796-1789. 630 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
29 
 
http://www.icsoffice.org/Publications/ICI_4/book.pdf;  631 
https://pdfs.semanticscholar.org/0b60/32e462e6b0fd6f9a255d0035abe461f77faf.pdf 632 
 Accessed 3/04/18  633 
19. Devlin N, Parkin D, Browne J. (2010). Using the EQ-5D as a performance 634 
measurement tool in the NHS. Health Economics 19(8):886-905. 635 
20. Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH, Buesching DP. Quality of life with 636 
women with urinary incontinence: further development of the incontinence quality of life 637 
instrument (I-QOL). Urology. 1999; 53:71-76 638 
21. Estabrooks CA,Squires JE, Cummings GG, Birdsell JM, Norton PG. Development and assessment 639 
of the Alberta Context Tool.  BMC Health Services Research. 2009; 9:234 DOI: 10.1186/1472-6963-640 
9-234 641 
22. Squires JE, Hayduk L, Hutchinson AM, Mallick R, Norton PG, Cummings GG, Estabrooks CA. 642 
Reliability and validity of the Alberta Context Tool (ACT) with professional nurses: findings from a 643 
multi-study analysis. PLoS One. 2015; 10(6):e0127405 644 
23. Campbell MK, Mollison J, Steen N, Grimshaw JM &Eccles M (2000) Analysis of cluster 645 
randomized trials in primary care: a practical approach. Family Practice 17:192-196. 646 
24. Donner A & Klar N (2000) Design and analysis of cluster randomized trials in health research. 647 
Arnold. London. 648 
25. Pawson R. The Science of Evaluation: A Realist Manifesto. Sage, London. 2013 649 
26. Brooks G, Burton M, Cole P, Miles J, Torgerson C & Torgerson D (2008) Randomised controlled 650 
trial of incentives to improve attendance at adult literacy classes. Oxford Review of Education 651 
34:493-504. 652 
27. Eriksson L, Huy TQ, Duc DM, Ekholm Selling K, Hoa DP, Thuy NT, Nga NT, Wallin L. Process 653 
evaluation of a knowledge translation intervention using facilitation of local stakeholder groups to 654 
improve neonatal survival in the Quang Ninh province, Vietnam. Trials. 2016;17:23. 655 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
30 
 
28. McCormack B, Rycroft-Malone J, DeCorby K, Hutchinson AM, Bucknall T, Kent B, Schultz A, 656 
Snelgrove-Clarke E, Stetler C, Titler M ,Wallin L, Wilson L. A realist review of interventions and 657 
strategies to promote evidence-informed healthcare: a focus on change agency. Implementation 658 
Science. 2013; 8:107 DOI: 10.1186/1748-5908-8-107 659 
29. Baskerville B, Liddy C, Hogg W. Systematic Review and Meta-Analysis of Practice Facilitation 660 
within Primary Care Settings. Ann Fam Med. 2012;37(8):63-74 661 
30. Persson LÅ, Nguyen TN, Målqvist M, Dinh Thi Phuong H, Eriksson L, Wallin L, Tran QH, Duong 662 
MD, Tran VT, Vu Thi Thu T, Ewald U. Effect of facilitation of local maternal-and-child stakeholder 663 
groups on neonatal mortality. The NeoKIP cluster-randomised trial in Quang Ninh province, Vietnam. 664 
PLOS Medicine 2013;10(5). http://dx.doi.org/10.1371/journal.pmed.1001445 665 
31. Etheridge F, Couturier Y, Denis JL,Tremblay L, & Tannenbaum C. Explaining the success or failure 666 
of quality improvement initiatives in long term care organisations from a dynamic perspective. 667 
Journal of Applied Gerontology. 2014; 33(6):672-689 668 
32. Van der Zijpp TJ, Niessen T, Eldh A, Hawkes C, McMullan C, Mockford C, Wallin L, McCormack B, 669 
Rycroft-Malone J & Seers K.  A bridge over turbulent waters - illustrating the interaction between 670 
managerial leaders and facilitators when implementing research evidence. Worldviews on Evidence-671 
Based Nursing. 2016;13(1):25-31. doi: 10.1111/wvn.12138 672 
33. Hawe P. Lessons from complex interventions to improve health. Annual Review of Public 673 
Health. 2015; 36:307-323 674 
34. Pressman JL & Wildavsky A. Implementation. How great expectations in Washington are dashed 675 
in Oakland or Why it’s amazing that federal programs work at all this Being a Saga of the Economic 676 
Development Administration as Told by Two Sympathetic Observers Who Seek to Build Morals on a 677 
Foundation of Ruined Hopes. University of California Press, Berkeley. 1973 678 
35. Pressman JL & Wildavsky A. Implementation. How great expectations in Washington are dashed 679 
in Oakland; or Why it’s amazing that federal programs work at all this Being a Saga of the Economic 680 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
31 
 
Development Administration as Told by Two Sympathetic Observers Who Seek to Build Morals on a 681 
Foundation of Ruined Hopes. 3rd edition.  University of California Press, Berkeley. 1984  682 
36. Rycroft-Malone et al (linked paper) Jo Rycroft-Malone; Kate Seers; Ann Catrine Eldh; 683 
Karen Cox; Nicola Crichton; Gill Harvey; Claire Hawkes; Alison Kitson; Brendan George McCormack; 684 
Christel McMullan; Carole Mockford; Theo Niessen; Paul Slater; Angie Titchen; Teatske van der Zijpp; 685 
Lars Wallin.  A realist process evaluation within the Facilitating Implementation of Research 686 
Evidence (FIRE) cluster randomised controlled international trial: an exemplar. Accepted by 687 
Implementation Science. 688 
37. Harvey et al (linked paper)     Harvey G McCormack B Kitson A Lynch E Titchen A. Designing and 689 
implementing two facilitation interventions within the 'Facilitating Implementation of Research 690 
Evidence (FIRE)' study: A qualitative analysis from an external facilitators' perspective. Accepted by 691 
Implementation Science 692 
 693 
  694 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
32 
 
 695 
List of Abbreviations 696 
EF – External Facilitator 697 
FIRE - Facilitating Implementation of Research Evidence 698 
IF – Internal Facilitator  699 
PARIHS - Promoting Action on Research Implementation in Health Services 700 
UI – Urinary incontinence 701 
UTI – Urinary Tract Infection 702 
 703 
704 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
33 
 
 705 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Table 1: Summary statistics for EQ-5D-VAS scale for each intervention group 
Intervention 
Number of 
residents with 
completed scale 
Mean (SE 
robust)* 
95% CI for mean Range 
Standard 
Dissemination 
(Control) 
109 54.2 (4.737) 44.35, 64.00 0, 100 
Type A 113 59.2 (4.325) 50.19, 68.13 0, 100 
Type B 124 55.6 (2.918) 49.57, 61.67 0, 90 
*SE robust allows for the clustering, and ANOVA allowing for clustering to compare the three means, 
gave p=0.34 
 
Table 2: Multilevel mixed effect linear regression model – Percentage compliance with 
recommendation 1 (The resident should be actively screened for urinary incontinence), with 
adjustment of standard errors to allow for clustering. 
 Coefficient Std. Err. z P -value 
95% confidence 
interval 
Type A 2.9293 3.1298 0.94 0.349 -3.2049, 9.0635 
Type B -4.1688 3.6966 -1.13 0.259 -11.4141, 3.0765 
Sweden -31.0840 4.0940 -7.59 0.000 -39.1082, -23.0599 
Ireland 13.8449 4.5226 3.06 0.002 4.9808, 22.7091 
England 10.3152 5.0742 2.03 0.042 0.3699, 20.2604 
+ 6 months 0.1104 2.8436 0.04 0.969 -5.4630, 5.6837 
+ 12 months 12.9885 4.4264 2.93 0.003 4.3130, 21.6641 
+18 months 4.9052 3.3204 1.48 0.140 -1.6025, 11.4130 
+24 months 9.3776 4.3632 2.15 0.032 0.8259, 17.9292 
Constant 33.7259 4.2278 7.98 0.000 25.4396, 42.0122 
N=2313; Model fit: Wald 2(9)=1970.23, p<0.001; Post-estimation ICC 0.0910 (se 0.0219) 
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Table 3: Mean percentage compliance with recommendation 1 by intervention group for each time 
point 
N=2313 residents are included in this analysis 
Table 4: Multilevel mixed effect linear regression model - Percentage compliance with 
recommendation 2 (A detailed assessment should be carried out), with adjustment of standard 
errors to allow for clustering. 
 
Coefficient Std. Err. z P -value 
95% confidence 
interval 
Type A 5.6514 4.0014 1.41 0.158 -2.1912, 13.4941 
Type B 3.7903 4.4807 0.85 0.398 -4.9917, 12.5724 
Sweden -1.9108 2.7374 -0.70 0.485 -7.2760, 3.4545 
Ireland 14.9312 3.6627 4.08 0.000 7.7524, 22.1099 
England 11.7997 7.0278 1.68 0.093 -1.9745, 25.5738 
+ 6 months -0.2220 1.2763 -0.17 0.862 -2.7235, 2.2794 
+ 12 months 3.3623 2.1118 1.59 0.111 -0.7767, 7.5014 
+18 months -0.0031 1.6463 -0.00 0.998 -3.2298, 3.2235 
+24 months 4.4827 2.1665 2.07 0.039 0.2364, 8.7290 
Constant 30.1617 3.3204 9.08 0.000 23.6538, 36.6696 
N=2313; Model fit: Wald 2(9)=64.76, p<0.001; Post-estimation ICC 0.3517 (se 0.0758) 
 
 
Intervention 
Group 
Mean score 
Baseline  6 month  12 month  18 month  24 month  
Control 28.4  22.3 29.2  27.0 23.2  
Type A 19.2  21.5 38.8 30.6 35.5 
Type B 14.1  17.0  44.4 23.4 28.7 
Table 5: Mean percentage compliance with recommendation 2 by intervention group for each time 
point 
N=2313 residents are included in this analysis 
 
Table 6: Multilevel mixed effect linear regression model – Percentage compliance with 
recommendation 3 (An individualised treatment plan should be in place), with adjustment of 
standard errors to allow for clustering. 
 
Coefficient Std. Err. z P -value 
95% confidence 
interval 
Type A 0.3391 4.0168 0.08 0.933 -7.5336, 8.2118 
Type B 1.0372 3.0579 0.34 0.734 -4.9562, 7.0305 
Sweden 23.7959 1.9736 12.06 0.000 19.9278, 27.6640 
Ireland 24.5448 3.9162 6.27 0.000 16.8692, 32.2204 
England 15.3118 3.8489 3.98 0.000 7.7681, 22.8555 
+ 6 months 9.8431 4.1862 2.35 0.019 1.6382, 18.0479 
+ 12 months 14.2761 3.7488 3.81 0.000 6.9285, 21.6237 
+18 months 15.9399 3.7804 4.22 0.000 8.5305, 23.3494 
+24 months 19.9791 3.3984 5.88 0.000 13.3183, 26.6399 
Constant 6.5831 3.0927 2.13 0.033 0.5216, 12.6446 
N=2313; Model fit: Wald 2(9)=387.72, p<0.001; Post-estimation ICC 0.1265 (se 0.0502) 
 
Intervention 
Group 
Mean score 
Baseline  6 month  12 month  18 month  24 month  
Control 37.5  34.6 36.5 34.1  34.4  
Type A 34.6 35.1 45.1 39.7 44.6 
Type B 35.3 34.8 43.2 38.2 45.9 
Table 7: Mean percentage compliance with recommendation 3 by intervention group for each time 
point 
Intervention 
Group 
Mean score 
Baseline  6 month  12 month  18 month  24 month  
Control 20.9 30.8 40.9 45.0 48.9 
Type A 23.8 32.2 41.9 42.7 45.2 
Type B 26.7 38.6 40.7 41.1 45.9 
N=2313 residents are included in this analysis 
 
Table 8: Mean scores on ACT concepts by intervention group at baseline (N=725 staff are included in 
this analysis) 
ACT Concept* 
Number 
of items 
Range 
for score 
Control sites 
Mean (SD) 
Type A sites 
Mean (SD) 
Type B sites 
Mean (SD) 
Leadership# 6 1-5 3.6 (0.81) 3.7 (0.82) 3.7 (0.76) 
Culture# 6 1-5 3.9 (0.65) 3.9 (0.57) 3.9 (0.61) 
Feedback# 6 1-5 3.5 (0.79) 3.4 (0.82) 3.4 (0.85) 
Formal Interactions~ 4 0-4 1.3 (1.14) 1.1 (1.08) 1.2 (1.13) 
Informal 
Interactions~ 
9 or 10 0-10 3.5 (2.11) 3.2 (2.08) 3.3 (2.04) 
Connections (Social 
Capital)# 
6 1-5 4.0 (0.67) 3.8 (0.59) 3.9 (0.59) 
Structural & 
electronic resources~ 
11 0-11 3.1 (2.34) 3.4 (2.14) 2.8 (1.89) 
Organisational Slack- 
Staffing# 
3 1-5 2.7 (1.13) 2.8 (1.09) 2.6 (1.00) 
Organisational Slack- 
Space# 
3 1-5 3.6 (1.01) 3.1 (1.14) 3.3 (1.10) 
Organisational Slack- 
Time# 
4 1-5 2.8 (0.69) 2.8 (0.70) 2.8 (0.74) 
*Definitions of ACT concepts and scaling are provided21, 22 and relevant papers are listed at 
https://trecresearch.ca/alberta_context_tool. # scaled; ~count based 
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